DHANUKA Q1 FY27 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹494.61 Cr
verification pending
Revenue YoY
-12.56%
reported change
EBITDA
₹55.01 Cr
latest reported figure
Source
manual review required
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Dhanuka Agritech delivered a 12.56% revenue decline to ₹494.61 crore in Q1 FY27, significantly impacted by delayed monsoon onset—June rainfall was 40% below normal, affecting key herbicide-heavy markets in Rajasthan, Gujarat, Madhya Pradesh, and Maharashtra where cotton and soybean sowing faced re-sowing. EBITDA margin contracted 150bps YoY to 11.1% as fixed costs remained elevated despite revenue decline. The company flagged a steep guidance cut for FY27, projecting only small single-digit growth, acknowledging that Q2 also remains challenging as July rainfall deficits persist. Herbicide sales declined ~25%, but fungicides surprised with 11% YoY growth driven by specialty Japanese products in horticulture. The Dahanu technical plant posted ₹26 crore revenue with EBITDA loss of ~₹45 crore, while the new Nagpur formulation facility (23,000 MT capacity, ₹200 crore capex) is targeted for April 2028 commissioning with CGST incentives. Management remains focused on new product launches (5 products planned), international expansion from acquired Bayer/Iprodione products, and potential inorganic opportunities—all while maintaining a debt-free balance sheet. Key risk: continuation of monsoon weakness could further pressure H2 recovery. GST notice on biologicals remains under legal review with management confident of favorable outcome.
Colored figures show movement against the previous available record.
Guidance to track
- Management significantly cut full-year guidance citing continued monsoon uncertainty and weak demand environment. The company expects only modest growth despite prior expectations.
- Despite Q1 achieving ₹26 crore, full-year Dahanu guidance is ₹65 crore. EBITDA break-even remains difficult with expected loss of ~₹45 crore for the year.
- The new 23,000 MT formulation plant in Nagpur (Butibori industrial area) will incur ~₹100+ crore capex in FY27-28, targeting commissioning by April 2028 with automation and global safety standards.
- Pipeline includes 1 liquid fertilizer, 3 fungicides, and 1 herbicide. Additionally, 3 biological products being launched (2 already introduced, 3rd by August end) plus 2 more nutrition biologicals in FY27.
Risks flagged
- Despite July improvement, large parts of the country remain rainfall-deficient. Q2 (July-September) is critical kharif season and management explicitly stated Q2 will also be difficult, with acreage potentially lower than last year.
- Price increases attempted in April (due to West Asia geopolitical costs) could not be sustained from May onward as demand remained weak. Value and volume declines were nearly identical (~12.5-12.7%), indicating no pricing power.
- The technical plant continues to burn cash with expected EBITDA loss of ~₹45 crore in FY27 despite achieving ₹26 crore Q1 revenue. Break-even remains elusive, creating ongoing drag on consolidated profitability.
- A GST notice on biologicals (fertilizer category at 5% rate) is under legal review with Lakshmi Kumaran as consultant. Management expressed confidence but timeline for resolution was not provided.
Key quotes
- We are looking at a small single-digit growth I would say.
- This is probably not the right time for me to come on the asset turns part but I think so we'll be able to come back and address this towards once the project details and everything are deeply finalized which is probably late last Q4.
- The design of the regulation is absolutely in track with our forecast that the smaller players and the unorganized players would probably not have enough space to operate.
Research modules